Yu Xing, Ji Caihong, Shao Anwen
Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Front Neurosci. 2020 Apr 29;14:334. doi: 10.3389/fnins.2020.00334. eCollection 2020.
The neurovascular unit (NVU), composed of vascular cells, glial cells, and neurons, is the minimal functional unit of the brain. The NVU maintains integrity of the blood-brain barrier (BBB) and regulates supply of the cerebral blood flow (CBF), both of which are keys to maintaining normal brain function. BBB dysfunction and a decreased CBF are early pathophysiological changes in neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). In this review, we primarily focus on the NVU in AD as much research has been performed on the connection between NVU dysfunction and AD. We also discuss the role of NVU dysfunction in the pathophysiological mechanisms of PD and ALS. As most neurodegenerative diseases are difficult to treat, we discuss several potential drug targets that focus on the NVU that may inform novel vascular-targeted therapies for AD, PD, and ALS.
神经血管单元(NVU)由血管细胞、神经胶质细胞和神经元组成,是大脑的最小功能单元。NVU维持血脑屏障(BBB)的完整性并调节脑血流量(CBF),这两者都是维持正常脑功能的关键。BBB功能障碍和CBF减少是神经退行性疾病(如阿尔茨海默病(AD)、帕金森病(PD)和肌萎缩侧索硬化症(ALS))早期的病理生理变化。在本综述中,由于已经对NVU功能障碍与AD之间的联系进行了大量研究,我们主要关注AD中的NVU。我们还讨论了NVU功能障碍在PD和ALS病理生理机制中的作用。由于大多数神经退行性疾病难以治疗,我们讨论了几个针对NVU的潜在药物靶点,这些靶点可能为AD、PD和ALS的新型血管靶向治疗提供依据。